| Year | Number1 | Mid-year population2 | Cases / 100,000 population | Number (%) resistant to mupirocin |
|---|---|---|---|---|
| 2007 | 173 | 6 916 300 | 2.5 | Data not available |
| 2008 | 282 | 6 957 800 | 4.1 | Data not available |
| 2009 | 368 | 6 972 800 | 5.3 | Data not available |
| 2010 | 495 | 7 024 200 | 7.0 | Data not available |
| 2011 | 624 | 7 071 600 | 8.8 | Data not available |
| 2012 | 815 | 7 150 100 | 11.4 | Data not available |
| 2013 | 990 | 7 178 900 | 13.8 | Data not available |
| 2014 | 997 | 7 229 500 | 13.8 | 6 (0.60) |
| 2015 | 1046 | 7 291 300 | 14.3 | 6 (0.57) |
| 2016 | 1167 | 7 336 600 | 15.9 | 4 (0.34) |
| 2017 | 1258 | 7 391 700 | 17.0 | 5 (0.40) |
| 2018 | 1218 | 7 451 000 | 16.3 | 7 (0.57) |
| 2019 | 1236 | 7 507 400 | 16.5 | 4 (0.32) |
| 2020 | 810 | 7 481 800 | 10.8 | 7 (0.86) |
| 2021 | 582 | 7 413 100 | 7.8 | 1 (0.17) |
| 2022 | 416 | 7 346 100 | 5.7 | 3 (0.72) |
| 2023 | 469 | 7 536 100 | 6.2 | 4 (0.85) |
1https://www.chp.gov.hk/en/static/24012.html
2https://www.censtatd.gov.hk/hkstat/sub/so20.jsp
Download Community-associated methicillin resistant Staphylococcus aureus infection (in CSV format)| Antimicrobial | Year | |||||
|---|---|---|---|---|---|---|
| 2019 | 2020 | 2021 | 2022 | 2023 | ||
| Clindamycin | Cases tested | 774 | 534 | 422 | 301 | 351 |
| % Susceptible | 66.9 | 68.2 | 67.8 | 71.4 | 68.4 | |
| % Resistant | 33.1 | 31.6 | 32.0 | 28.6 | 31.3 | |
| Erythromycin | Cases tested | 852 | 568 | 533 | 381 | 429 |
| % Susceptible | 47.8 | 52.5 | 52.9 | 57.0 | 51.0 | |
| % Resistant | 48.2 | 45.4 | 43.5 | 40.9 | 47.1 | |
| Doxycycline | Cases tested | 212 | 128 | 90 | 91 | 64 |
| % Susceptible | 87.3 | 85.2 | 91.1 | 89.0 | 85.9 | |
| % Resistant | 3.3 | 3.1 | 1.1 | 7.7 | 4.7 | |
| Minocycline | Cases tested | 129 | 88 | 74 | 88 | 63 |
| % Susceptible | 100 | 100 | 100 | 90.9 | 96.8 | |
| % Resistant | 0 | 0 | 0 | 8.0 | 3.2 | |
| Gentamicin | Cases tested | 788 | 497 | 453 | 326 | 371 |
| % Susceptible | 90.2 | 88.1 | 90.9 | 89.6 | 86.5 | |
| % Resistant | 8.1 | 10.1 | 6.8 | 8.6 | 12.1 | |
| Co-trimoxazole | Cases tested | 981 | 620 | 458 | 328 | 384 |
| % Susceptible | 97.3 | 97.6 | 97.4 | 97.3 | 98.7 | |
| % Resistant | 2.4 | 1.8 | 2.2 | 2.4 | 1.3 | |
| Total cases notified in year | 1,236 | 810 | 582 | 416 | 469 | |